Global Plant-Based Vaccines Market

Report ID : 1453 | Published : 2022-11-24 | Pages: 160 | Format: PDF/EXCEL

The market size of the Global Plant-Based Vaccines Market in the year 2021 is valued at 1.27 billion and is predicted to reach 2.52 billion by the year 2030 at an 8.07% CAGR during the forecast period of 2022-30. A vital ingredient in the creation of accessible vaccination derivatives is planted life. Plant-based vaccine production reduces the financial burden of infectious diseases in developing countries because of its large production volume and low cost. Numerous clinical trials focus on developing plant-based oral vaccines for therapeutic indications such as influenza, dengue fever, the flu, and the Ebola virus. By avoiding the use of syringes and needles, these immunizations can be given orally, freeing up medical staff for other tasks and reducing the risk of hospitals acquired infections. Due to rising public awareness of these vaccines' benefits and the global spread of infectious diseases, the market for plant-based vaccines is predicted to experience considerable growth during the projection. Plant-based vaccines are also less expensive and do not require cold-chain shipping. They are easy to store, and adding more space for production is straightforward. The market for vaccines made from plants is expected to grow. To develop plant-based vaccines for various medical applications, the existing and future market participants for plant-based vaccines are concentrating on rigorous clinical practice assessments.

Furthermore, shortly, it was anticipated that the inadequacies, potential for contamination, and environmental issues would restrain the expansion of the global market for plant-based biologics. Pollen can harm non-transgenic harvests, a part of the conventional agricultural exhibition. Pollen contamination incidents in field crop-based Plant Molecular Farming (PMF) outlets, such as those based on maize or rice, expand biosafety situations. Creating recombinant pharmaceutical combinations is now strictly prohibited by U.S. FDA regulations.

Market Segmentation:

The plant-based vaccines market is segmented on the type, application and source. Based on type, the market is segmented into viral vaccines, bacterial vaccines and others. Based on application, the plant-based vaccines market is segmented into influenza, zika virus, ebola virus and others. Based on source, the plant-based vaccines market is segmented into maize, tobacco, potatoes and others.

Based on type, the viral vaccines segment is accounted as a major contributor to the plant-based vaccines market.

Based on type, the market is segmented into viral vaccines, bacterial vaccines and others. The viral vaccines category grabbed the highest revenue share, and it is anticipated that it will continue to hold that position during the anticipated time. Numerous studies have shown that transgenic plants can appropriately translate and digest bacterial toxin components and viral epitopes. Recombinant proteins activate immune responses and provide increased safety, economy, stability, adaptability, and efficacy compared to current vaccine technologies, leading to a larger market share.

The influenza segment witnessed growth at a rapid rate.

Based on application, the plant-based vaccines market is segmented into influenza, zika virus, ebola virus and others. The influenza category is anticipated to grow significantly over the forecast period. The influenza virus brings on a form of respiratory infection called influenza. Spreading is simple. To protect people against influenza, several market participants in the plant-based vaccination space are working to create precise and potent vaccine candidates.

A prime example is the quadrivalent influenza vaccine (QIV) from Medicago. Health authorities are presently evaluating the vaccine, which promotes a well-balanced cellular and antibody immune response and is effective against various influenza viruses. The market for plant-based vaccines will have strong growth potential thanks to similar discoveries.

The North American plant-based vaccines market holds a significant regional revenue share.

The North American plant-based vaccines market is expected to register the highest market share in revenue shortly due to the development of new byproducts. The rising prevalence of influenza conditions in the local market and the expansion of several private and public research organizations dedicated to R&D activities for the development of plant-based vaccines, a massive industrial base, a strong consumer base with high purchasing power, particularly in developed nations like the U.S. and Canada, are other factors contributing to the expansion. Additionally, the Asia Pacific is anticipated to expand significantly over the forecast period due to the rise in infectious disease cases brought on by the climate of the region and the growing popularity of plant-based vaccines over conventional vaccines among the general public.

 

Competitive Landscape

Some major key players in the plant-based vaccines market are Creative Biolabs, Medicago Inc., iBio, ICON, EEA Consulting Engineers, Kentucky BioProcessing, Inc., Baiya Phytopharm and Protalix Biotherapeutics.

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Plant-based Vaccines Market Snapshot

Chapter 4. Global Plant-based Vaccines Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Investment and Funding Analysis

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. Competitive Landscape & Market Share Analysis

4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: By Product Type Estimates & Trend Analysis

5.1. By Product Type & Market Share, 2019 & 2030

5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2030 for the following by Product Type:

5.2.1. Viral Vaccines

5.2.2. Bacterial Vaccines

5.2.3. Others

Chapter 6. Market Segmentation 2: By Application Estimates & Trend Analysis

6.1. By Application & Market Share, 2019 & 2030

6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2030 for the following by Application:

6.2.1. Influenza

6.2.2. Zika Virus

6.2.3. Ebola Virus

6.2.4. Others

Chapter 7. Market Segmentation 3: By Source Estimates & Trend Analysis

7.1. By Source & Market Share, 2019 & 2030

7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2030 for the following by Source:

7.2.1. Maize

7.2.2. Tobacco

7.2.3. Potatoes

7.2.4. Others

Chapter 8. Plant-based Vaccines Market Segmentation 4: Regional Estimates & Trend Analysis

8.1. North America

8.1.1. North America Plant-based Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2022-2030

8.1.2. North America Plant-based Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Application, 2022-2030

8.1.3. North America Plant-based Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Source, 2022-2030

8.1.4. North America Plant-based Vaccines Market Revenue (US$ Million) Estimates and Forecasts by country, 2022-2030

8.2. Europe

8.2.1. Europe Plant-based Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2022-2030

8.2.2. Europe Plant-based Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Application, 2022-2030

8.2.3. Europe Plant-based Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Source, 2022-2030

8.2.4. Europe Plant-based Vaccines Market Revenue (US$ Million) Estimates and Forecasts by country, 2022-2030

8.3. Asia Pacific

8.3.1. Asia Pacific Plant-based Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2022-2030

8.3.2. Asia Pacific Plant-based Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Application, 2022-2030

8.3.3. Asia-Pacific Plant-based Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Source, 2022-2030

8.3.4. Asia Pacific Plant-based Vaccines Market Revenue (US$ Million) Estimates and Forecasts by country, 2022-2030

8.4. Latin America

8.4.1. Latin America Plant-based Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2022-2030

8.4.2. Latin America Plant-based Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Application, 2022-2030

8.4.3. Latin America Plant-based Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Source, 2022-2030

8.4.4. Latin America Plant-based Vaccines Market Revenue (US$ Million) Estimates and Forecasts by country, 2022-2030

8.5. Middle East & Africa

8.5.1. Middle East & Africa Plant-based Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2022-2030

8.5.2. Middle East & Africa Plant-based Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Application, 2022-2030

8.5.3. Middle East & Africa Plant-based Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Source, 2022-2030

8.5.4. Middle East & Africa Plant-based Vaccines Market Revenue (US$ Million) Estimates and Forecasts by country, 2022-2030

Chapter 9. Competitive Landscape

9.1. Major Mergers and Acquisitions/Strategic Alliances

9.2. Company Profiles

9.2.1. Creative Biolabs

9.2.2. Medicago Inc.

9.2.3. iBio

9.2.4. ICON

9.2.5. EEA Consulting Engineers

9.2.6. Kentucky BioProcessing, Inc.

9.2.7. Baiya Phytopharm

9.2.8. Protalix Biotherapeutics

9.2.9. Other Prominent Players

By Type-

  • Viral Vaccines
  • Bacterial Vaccines
  • Others

By Application-

  • Influenza
  • Zika Virus
  • Ebola Virus
  • Others

By Source-

  • Maize
  • Tobacco
  • Potatoes
  • Others

By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

Need Complete Report ?
Our Clients